ScreenerHero

GEHC GE HealthCare Technologies Inc.

NAS · US · Healthcare · Medical Devices · gehealthcare.com
65.74USD+2.26%Mkt Cap: 29.90B $P/E: 15.11

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$174.36BUSDP/E 32.3
MDT
Medtronic plc
$112.53BUSDP/E 21.6
SYK
Stryker Corporation
$109.40BUSDP/E 29.6
BSX
Boston Scientific Corporation
$61.45BUSDP/E 17.2
EW
Edwards Lifesciences Corporation
$50.23BUSDP/E 51.9
SHL
Siemens Healthineers AG
$46.06BUSDP/E 19.2
DXCM
DexCom, Inc.
$32.79BUSDP/E 34.5
PHG
Koninklijke Philips N.V.
$23.37BUSDP/E 17.8
PHIA
Koninklijke Philips N.V.
$22.58BUSDP/E 18.5
STE
STERIS plc
$20.58BUSDP/E 25.8
SOON
Sonova Holding AG
$17.06BUSDP/E 27.9
ZBH
Zimmer Biomet Holdings, Inc.
$17.47BUSDP/E 22.2
TXG
10x Genomics, Inc.
$12.73BUSD
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.27BUSDP/E 18.3
GMED
Globus Medical, Inc.
$10.28BUSDP/E 19.6
BIO
Bio-Rad Laboratories, Inc.
$10.16BUSDP/E 48.1
DEMANT
Demant A/S
$9.81BUSDP/E 27.8
BRKR
Bruker Corporation
$9.73BUSD
GKOS
Glaukos Corporation
$9.67BUSD

Key Statistics

Company
Market Cap29.90B USD
Enterprise Value37.74B USD
Revenue (TTM)21.27B USD
Gross Profit8.25B USD
Net Income (TTM)2.08B USD
Revenue/Share46.79 USD
Last Price65.74 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees54.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)15.11
P/E (Forward)11.88
PEG1.60
EV/EBITDA10.51
EV/Revenue1.77
P/S1.38
P/B2.65
EPS (TTM)4.35
EPS (Forward)5.41
52W Range
58.7523% of range89.77
52W High89.77 USD
52W Low58.75 USD
Profitability
Gross Margin39.99%
Oper. Margin14.98%
EBITDA Margin16.90%
Profit Margin10.10%
ROE20.08%
ROA5.65%
Growth
Revenue Growth5.80%
Earnings Growth16.80%
Cash Flow & Leverage
Operating CF1.99B USD
CapEx (TTM)482.00M USD
FCF Margin7.40%
FCF Yield5.26%
Net Debt8.46B USD
Net Debt/EBITDA2.36
Balance Sheet
Debt/Equity1.01
Current Ratio1.26
Quick Ratio0.83
Book Value/Sh24.30 USD
Cash/Share4.60 USD
Dividends
Fwd Div Rate0.16 USD
Trail. Div Rate0.14 USD
Div. Yield0.25%
5Y Avg Yield—
Payout Ratio3.22%
Ex-Div DateOct 23, 2026
Pay DateNov 13, 2026
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)83.05 USD
Upside (mean)+26.3%
Target Range70.00 USD – 96.00 USD
70.00+26.3% to mean96.00
# Analysts19
Ownership
Shares Out.454.89M
Float450.20M
Insiders0.37%
Institutions94.00%
Short Interest
Short Ratio6.0d
Short % Float4.24%
Short % Out.3.74%
Shares Short16.91M
Short (prev mo.)17.43M
Technical
SMA 5068.72 (-4.3%)
SMA 20071.28 (-7.8%)
Beta0.82
S&P 52W Chg14.58%
Avg Vol (30d)3.10M
Avg Vol (10d)3.55M
Technical Indicators
RSI (14)45.8
MACD-0.9251
MACD Signal-0.9058
MACD Hist.-0.0193
BB Upper68.92 USD
BB Middle65.70 USD
BB Lower62.47 USD
BB Width9.82%
ATR (14)1.574 USD
Vol Ratio (20d)1.06x